Showing 931 results

Filters Content type: News, Editors' picks Topic: Side effects

The most common side effects of anti-HIV drugs are short term and are the result of the body getting used to a new drug. Long-term adverse effects and toxicities are less common.

PrEP

Short- or Medium-Term PrEP Is Safer Than Aspirin

Editor's pick
AIDSMeds
13 January 2016
PrEP

South African Medicines Agency approves PrEP

Editor's pick
South African MCC
8 December 2015
PrEP

Ipergay PrEP study results published

News
2 December 2015
HIV treatment

Priorities for HIV care: the perspectives of healthcare providers and patients

News
2 November 2015
Weight gain & lipodystrophy

Body fat changes and lactic acidosis with HIV medicines: EMA recommends removal of class warnings for several medicines

Editor's pick
European Medicines Agency
26 October 2015
HIV treatment

Benefits of early HIV treatment are clear, but issues raised by START and D:A:D remain unresolved

News
23 October 2015
New & experimental HIV treatments

Studies continue to support tenofovir alafenamide combination pill as it nears US approval

News
19 October 2015
Side effects

TAF and TDF Compared for Kidney, Bone Toxicity in Black HIV+ Patients

Editor's pick
Monthly Prescribing Reference
12 October 2015
Side effects

Doctors Find Effective HIV Drug Course Free of Efavirenz

Editor's pick
Healthline
8 October 2015
Bone & joint problems

Bone loss slows, but continues long-term in HIV-positive people on antiretroviral therapy

News
14 September 2015
Changing treatment

Rilpivirine + darunavir HIV maintenance regimen matches standard three-drug antiretroviral therapy

News
10 September 2015
New & experimental HIV treatments

Tenofovir Alafenamide Combo Pill Matches Truvada for HIV Efficacy, but Easier on Bones and Kidneys

Editor's pick
HIVandHepatitis.com
4 September 2015
Changing treatment

Switching to new tenofovir alafenamide keeps virus in check and improves kidney and bone health

News
28 July 2015
HIV treatment

New NNRTI doravirine suppresses HIV as well as efavirenz but with fewer central nervous system side-effects

News
23 July 2015
Cardiovascular disease

Five antiretroviral combinations associated with increased risk of a cardiovascular event

News
8 May 2015
Treatment guidelines

US guidelines shift to integrase-based combinations for first-line treatment: Atripla relegated due to side effects

Editor's pick
i-Base
6 May 2015
Side effects

Ritonavir concentrations not correlated with lipid levels in people with HIV taking boosted atazanavir or boosted darunavir

News
6 April 2015
Undetectable viral load & treatment as prevention

Chinese study sheds light on how well treatment may work as prevention in the real world

News
1 April 2015
Neurological & cognitive problems

Predictors of HIV-related peripheral neuropathy in the modern era

Editor's pick
CATIE
1 April 2015
Access to healthcare

Most HIV-positive gay men in European survey are on HIV treatment, though fewer in the east

News
30 March 2015
Weight gain & lipodystrophy

Does HIV make you fat? Study connects viral load with fat gains

News
6 March 2015
Side effects

Tenofovir, boosted atazanavir and boosted lopinavir are associated with cumulative risk of developing chronic kidney disease

News
27 February 2015
HIV treatment

Tenofovir alafenamide equally effective but safer for kidneys and bones than current formulation

News
27 February 2015
Side effects

HIV Organizations Urge Continuation of D:A:D Study

Editor's pick
Treatment Action Group
11 February 2015